Colorectal cancer in patients with early onset is distinct from that in older patients

March 11, 2019

New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed certain unique features in especially young patients and those with predisposing conditions.

Although incidence and mortality rates of colorectal cancer have fallen in patients aged 50 years and older, early-onset colorectal cancer rates have been increasing over the past two decades. To look for differences between early-onset and late-onset colorectal cancer, investigators at The University of Texas MD Anderson Cancer Center in Houston analyzed information on more than 36,000 colorectal cancer patients.

The researchers found that younger patients were more likely to have certain genetic mutations and certain subtypes of colorectal cancer than older patients. Also, among patients with early-onset colorectal cancer, very young patients (aged 18-29 years) were unique from older patients (aged 30-49 years) in terms of the clinical and genetic features of their cancer. Likewise, patients with early-onset colorectal cancer who had predisposing conditions, such as inflammatory bowel disease, had different clinical and genetic characteristics compared with patients without predisposing conditions.

"We need to appreciate that there are unique biologic subtypes within young patients that may affect how their cancers behave and may require a personalized approach to treatment," said senior author Jonathan Loree, MD. "Going forward, special clinical consideration should be given to, and further scientific investigations should be performed for, both very young patients with colorectal cancer and those with predisposing medical conditions."

March is Colorectal Cancer Awareness Month.
-end-
Additional information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Penny Smith +44 (0) 1243 770448 (UK)
Josh Glickman +1 201-748-6572 (US)
newsroom@wiley.com

Follow us on Twitter @WileyNews

Full Citation:

"Clinical and Molecular Characterization of Early-Onset Colorectal Cancer. "Alexandra N. Willauer, Yusha Liu, Allan A.L. Pereira, Michael Lam, Jeffrey S. Morris, Kanwal P.S. Raghav, Van K. Morris, David Menter, Russell Broaddus, Funda Meric-Bernstam, Andrea Hayes-Jordan, Winston Huh, Michael J. Overman, Scott Kopetz, and Jonathan M. Loree. CANCER; Published Online: March 11, 2019 (DOI:10.1002/cncr.31994).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.31994

Author Contact:

The Media Specialists at MD Anderson Cancer Center can be contacted at 713-792-0655 or PublicRelations@mdanderson.org. Dr. Loree is now working at BC Cancer, whose media relations can be reached at 778-867-7472 or media@bccancer.bc.ca. All other authors are still affiliated with MD Anderson.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.

Follow us on Twitter @JournalCancer

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at http://www.wiley.com.

Wiley

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.